Zhong Q. Wang

3.1k citations
47 papers · 2.4k indexed · h-index 28
Topics
Adipose Tissue and Metabolism (10 papers)Chromium effects and bioremediation (9 papers)Metabolism, Diabetes, and Cancer (7 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Zhong Q. Wang

46 papers receiving 2.3k citations

Peers

Zhong Q. Wang
Comparison fields: 5 of 122
  • Physiology 654
  • Molecular Biology 651
  • Health, Toxicology and Mutagenesis 494
  • Endocrinology, Diabetes and Metabolism 465
  • Epidemiology 288
Replace Cemal Orhan with:
Cemal Orhan Türkiye
Atilla Engin Türkiye
Katsura Mizushima Japan
Wei Yang China
Jie Xu China
Shigetada Furukawa Japan
Chong‐Kuei Lii Taiwan
Paola Lucia Minciullo Italy
Yinhua Ni China
Xiaojiao Zheng China
Zhong Q. Wang relative to Cemal Orhan Türkiye Cemal Orhan's profile →
Citations per field
00.5×2.6×
Cemal Orhan · 1×
Citations per year

Countries citing papers authored by Zhong Q. Wang

Since Specialization
Citations

This map shows the geographic impact of Zhong Q. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong Q. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong Q. Wang more than expected).

Fields of papers citing papers by Zhong Q. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong Q. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong Q. Wang. The network helps show where Zhong Q. Wang may publish in the future.

Co-authorship network of co-authors of Zhong Q. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong Q. Wang. A scholar is included among the top collaborators of Zhong Q. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong Q. Wang. Zhong Q. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 12
3 10
4 10
5 21
6 3
7 17
8 63
9 36
10 53
11 95
12 26
13 44
14 57
15 184
16 163
17 7
18 12
19 39
20 182

About Zhong Q. Wang

Zhong Q. Wang is a scholar working on Aging, Pharmacy and Geriatrics and Gerontology, having authored 47 papers that have together received 2.4k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (10 papers), Chromium effects and bioremediation (9 papers) and Metabolism, Diabetes, and Cancer (7 papers). The work is most often cited by research in Pharmacy (184 citations), Health, Toxicology and Mutagenesis (494 citations) and Aging (50 citations). Zhong Q. Wang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include William T. Cefalu, Xian H. Zhang, David Ribnicky, Yongmei Yu, Audrey D. Bell–Farrow, James C. Russell, Ilya Raskin, James G. Terry, Z. Elizabeth Floyd and Julie Martin. Their work appears in journals such as PLoS ONE, American Journal of Clinical Nutrition and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026